References
- Mabie W C, Barton J R, Sibai B M. Septic shock in pregnancy. Obstet Gynecol 1997; 90: 553–561
- Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker J K, Van Meter S H, Poukens V, Whiteman D B, Iton A, Cheung M, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005; 353: 2352–2360
- Menacker F, Declercq E, Macdorman M F. Cesarean delivery: Background, trends, and epidemiology. Semin Perinatol 2006; 30: 235–241
- Wallach E E, Vlahos N F. Uterine myomas: An overview of development, clinical features, and management. Obstet Gynecol 2004; 104: 393–406
- Monk B J, Berman M L, Montz F J. Adhesions after extensive gynecologic surgery: Clinical significance, etiology, and prevention. Am J Obstet Gynecol 1994; 170: 1396–1403
- Silver R M, Landon M B, Rouse D J, Leveno K J, Spong C Y, Thom E A, Moawad A H, Caritis S N, Harper M, Wapner R J, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107: 1226–1232
- O'Boyle C J, MacFie J, Mitchell C J, Johnstone D, Sagar P M, Sedman P C. Microbiology of bacterial translocation in humans. Gut 1998; 42: 29–35
- MacFie J, O'Boyle C, Mitchell C J, Buckley P M, Johnstone D, Sudworth P. Gut origin of sepsis: A prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223–228
- Jeejeebhoy K N. Total parenteral nutrition: Potion or poison?. Am J Clin Nutr 2001; 74: 160–163
- MacFie J, Reddy B S, Gatt M, Jain P K, Sowdi R, Mitchell C J. Bacterial translocation studied in 927 patients over 13 years. Br J Surg 2006; 93: 87–93
- Smit W J, Boquest A L, Geddes J E, Tosolini F A. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management. Pathology 1994; 26: 321–324
- Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: Implications for therapy. Antimicrob Agents Chemother 1994; 38: 624–627
- Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner F D, Jonas D. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: Data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). J Hosp Infect 2006; 64: 238–243
- Metan G, Hayran M, Hascelik G, Uzun O. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 2006; 38: 527–531